AND EXCHANGE COMMISSION
to Section 13 or 15(d) of the
Exchange Act of 1934
of Report (date of earliest event reported): September 19, 2018
FARGO & COMPANY
name of registrant as specified in its charter)
|(State or other jurisdiction
Montgomery Street, San Francisco, California 94104
of principal executive offices) (Zip Code)
telephone number, including area code: 1-866-249-3302
name or former address, if changed since last report)
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405)
or Rule 12b-2 of the Exchange Act (17 CFR 240.12b-2).
growth company ☐
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Statements and Exhibits|
Exhibits are filed
herewith in connection with the Registration Statement on Form S-3 (File No. 333-221324) filed by Wells Fargo &
Company with the Securities and Exchange Commission.
On September 19,
2018, Wells Fargo & Company issued the following securities: (i) Medium-Term Notes, Series S, Principal at Risk Securities
Linked to the SPDR® S&P® Biotech ETF due September 21, 2020; and (ii) Medium-Term Notes, Series
T, Notes due September 19, 2021 (collectively, the “Notes”).
The purpose of
this Current Report is to file with the Securities and Exchange Commission the form of Note related to each issuance and the opinion
of Faegre Baker Daniels LLP regarding the Notes.
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
||WELLS FARGO & COMPANY|
|DATED: September 19, 2018
||/s/ Le Roy Davis|
||Le Roy Davis|
||Senior Vice President and Assistant Treasurer|